OTCPK:EMIS - Post by User
Post by
SCCNewsServiceson Apr 19, 2000 5:31pm
287 Views
Post# 1814508
Stock rises after
Stock rises after Drug delivery specialist Emisphere Technologies Inc.?s (NASDAQ: EMIS) stock rose as much as 20% after the company said human trials showed that its capsule version of a widely-used anti-clotting drug is effective.
Tarrytown, N.Y.-based Emisphere, which is also working on a liquid version of the generic anti-clotting drug heparin, said the capsule form was twice as effective as the liquid, which is in large-scale human trials.
To read the full story click on: https://www.smallcapcenter.com/story.asp?&mb=1storytype=sccne...